8-K 1 form8-k_jun032002.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 3, 2002 DISEASE SCIENCES, Inc. (Exact name of registrant as specified in its charter) Delaware 0-27865 13-264091 -------------------------------------------------------------------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification No.) formation) 620 Herndon Parkway, Suite 360, Herndon, Virginia 20170 -------------------------------------------------- --------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (703) 563-6565 Item 8. Change in Fiscal Year Disease Sciences, Inc. determined at a meeting of its Board of Directors held on June 3, 2002 to change its fiscal year from the current time period February 1 to January 31 to a fiscal year that starts on October 1 and ends on September 30. The date on which the new fiscal year ends will be September 30, 2002. A transition report will not be required. A Form 10QSB for the period October 1, 2001 through March 31, 2002 will be filed as soon as possible but not later than July 15, 2002. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly authorized and caused the undersigned to sign this report on the registrant's behalf. DISEASE SCIENCES, INC. By: /s/ John R. Signorello ------------------------ Name: John R. Signorello Title: CEO Dated: June 17, 2002